ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Peter Pastuszko
David F. Wilson
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zaitseva, T.
Right arrow Articles by Pastuszko, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zaitseva, T.
Right arrow Articles by Pastuszko, A.
Related Collections
Right arrow Cerebral protection

Ann Thorac Surg 2006;82:2247-2253
© 2006 The Society of Thoracic Surgeons


Original Articles: Cardiovascular

Regulation of Brain Cell Death and Survival After Cardiopulmonary Bypass

Tatiana Zaitseva, PhDa, Steven Schultz, MDb, Gregory Schears, MDc, Peter Pastuszko, MDd,*, Scott Markowitz, MDe, William Greeley, MDe, David F. Wilson, PhDa, Anna Pastuszko, PhDa

a Department of Biochemistry and Biophysics, The University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania
b Department of Pediatrics, The University of Miami, Miami, Florida
c Department of Anesthesia, The Mayo Clinic, Rochester, Minnesota
d Department of Surgery, The University of Oklahoma, Oklahoma City, Oklahoma
e Children’s Hospital of Philadelphia, Department of Anesthesiology and Critical Care, Philadelphia, Pennsylvania

Accepted for publication June 6, 2006.

* Address correspondence to Dr Pastuszko, Department of Biochemistry and Biophysics, 901 Stellar-Chance Bldg, University of Pennsylvania, Philadelphia, PA 19104 (Email: pastuszk{at}mail.med.upenn.edu).


    Abstract
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
BACKGROUND: This study investigated the effect of low flow cardiopulmonary bypass, circulatory arrest, and selective cerebral perfusion on expression and phosphorylation of selected regulators of cell death and survival in striatum of newborn piglets.

METHODS: Animals were assigned to sham operation and three experimental groups. The experimental groups were placed on bypass, cooled to 18°C, and subjected to 90 minutes of deep hypothermic circulatory arrest (DHCA), low-flow cardiopulmonary bypass (LFCPB) at mL/(kg · min), or selective cerebral perfusion (SCP) at 20 mL/(kg · min), followed by rewarming and 2 hours of recovery. The oxygen pressure in the microcirculation of the cortex was measured by quenching of phosphorescence. Levels of phosphorylated and total protein were determined by Western blot analysis.

RESULTS: Control oxygen pressure was 55 ± 9 mm Hg and decreased during DHCA, LFCPB, and SCP to 1.1 ± 0.6 mm Hg, 9.8 ± 2.3 mm Hg, and 9.3 ± 1.9 mm Hg, respectively (p < 0.001). After DHCA, N-terminal of Bcl-2-associated X protein (N-Bax) levels increased (295% ± 15%, p < 0.01), B-cell leukemia protein (Bcl-2) levels decreased (31% ± 9%, p < 0.01), and phosphorylation level of protein kinase B (pAkt) and extracellular signal-regulated kinase 1/2 (pERK1/2) did not change. After LFCPB and SCP, N-Bax and Bcl-2 levels were unchanged, pAkt levels increased (367% ± 122%, p < 0.05 and 337% ± 47%, p < 0.01, respectively), pERK1 (484% ± 70% and 501% ± 255%, respectively; p < 0.01) and pERK2 (569% ± 128%; p < 0.001 and 494% ± 162%; p < 0.05, respectively) levels increased, and total ERK2 levels also increased (279% ± 90% and 153% ± 44%, respectively, p < 0.05).

CONCLUSIONS: Stable levels of Bcl-2 and Bax and the increases in pAkt and pERK1/2 after LFCPB and SCP are likely indicators of improved chances for cell survival.


    Introduction
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Despite extensive studies on the pathophysiology of cardiopulmonary bypass and associated bypass techniques such as deep hypothermic circulatory arrest (DHCA), low-flow cardiopulmonary bypass (LFCPB), and selective cerebral perfusion (SCP), little is known about how a decrease in oxygen during these procedures affects the expression of genes, protein phosphorylation, and protein synthesis required to sustain the normal process of cell survival in the brain.

Several transcription proteins critical in the regulation of survival pathways or in cell death after hypoxia/ischemia have been identified, including the B-cell leukemia protein family (Bcl-2), protein kinase B (Akt), and mitogen-activated protein kinase family (MAPK). The Bcl-2 family includes both proapoptotic and antiapoptotic proteins [1]. The balance between these two proteins of the Bcl-2 family largely determines the survival or death of a cell. The Akt is a component of many receptor signal-transduction pathways and can prevent cell death after growth factor withdrawal [2]. Akt exerts its antiapoptotic effects through several downstream targets, including the cyclic adenosine monophosphate response element-binding protein (CREB). The MAPK family plays crucial roles in signal transduction from the cell surface to the nucleus and regulates cell death and survival. One member of the MAPK family, the extracellular signal-regulated kinase 1/2 (ERK1/2), has been proposed to play an important role in the pathogenesis of cerebral ischemic injury [3, 4] and also in neuroprotection [5]. The mechanisms of ERK1/2-mediated neuroprotection involve activation of the antiapoptotic proteins and inhibition of apoptotic proteins.

The goal of the present study was to determine expression of Bcl-2, an antiapoptotic protein, and Bax, a proapoptotic protein, and also changes in phosphorylation of Akt and ERK1/2 in the striatum of newborn piglets after DHCA, LFCPB, and SCP. We hypothesized that a prolonged period of severe hypoxia (DHCA) compared with mild hypoxia (LFCPB and SCP) would promote apoptosis and neuronal injury in the newborn brain.


    Material and Methods
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Animal Model
A total of 26 newborn piglets, 2 to 4 days old (1.4 to 2.5 kg), were randomly assigned to control-sham (n = 6), LFCPB (n = 6), DHCA (n = 8), or SCP (n = 6) groups. After induction with halothane, a tracheotomy was performed. The piglets were then placed on a ventilator, and anesthesia was maintained with fentanyl and pancuronium. Femoral venous and arterial cannulas were placed for the collection of samples and monitoring blood pressure. The head of the animal was placed in stereotaxis, the scalp was removed, and a cranial window approximately 8 mm in diameter was made over the right parietal hemisphere for measurement of cortical oxygen pressure. The control animals did not undergo cardiopulmonary bypass. They were anesthetized and then had a "sham" operation. The other three groups underwent a 1-hour stabilization period. CPB protocol was then performed, followed by 2 hours of recovery. The animals were then euthanized with 4 M potassium chloride, and the striata were immediately dissected and frozen for later analysis.

All animal procedures were in strict accordance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health, 1996) and were approved by the local Animal Care Committee.

Cardiopulmonary Bypass Technique and Experimental Protocol
Full CPB flow was set at 125 mL/(kg · min). Alpha-stat strategy was used in all CPB piglets to mimic the clinical setting used in the operating room. Anesthesia was maintained during CPB with isoflurane at 0.5 to 1.0 volume percentage, repeated intravenous (IV) pancuronium boluses of 0.1 mg/kg, and an IV fentanyl infusion of 10 µg /(kg · h). The mean blood pressure on full support was typically 50 to 60 mm Hg, and the hemoglobin was maintained at 10 to 11 g/dL. During recovery, mean blood pressures were maintained at the prebypass level of 70 to 80 mm Hg with normal saline and 5% albumin. No inotropic agents were used.

Once CPB was begun, the animals were cooled to a nasopharyngeal temperature of 18°C over 30 minutes. Ventilation was stopped after initiation of CPB.

Low-Flow hypothermic cardiopulmonary bypass
When the temperature reached 18°C, the CPB circuit flow was reduced to 20 mL/(kg · min). After 90 minutes of LFCPB, the flow was gradually increased again to 125 ml/(kg · min), and the piglets were rewarmed to 36°C over a 30-minute period.

Deep hypothermic cardiac arrest
When the temperature reached 18°C, CPB was stopped. After 90 minutes of DHCA, the flow was gradually increased again to 125 ml/(kg · min), and the piglets were rewarmed to 36°C over a 30-minute period.

Selective cerebral perfusion
Before the piglets were placed on CPB, the aortic arch and its vessels were exposed. Once the piglets reached the appropriate study temperature, the ascending aorta, transverse aorta, and left carotid artery were cross-clamped. The arterial cannula was advanced into the right carotid artery and the bypass flow rate was lowered to 20 ml/(kg · min). After 90-minute period, the cross-clamps were removed, the cannula was moved back into the ascending aorta, and CPB was slowly increased to 125 ml/(kg · min) during the 30-minute rewarming period.

Measurements of Oxygen Pressure and Oxygen Distribution by the Oxygen-Dependent Quenching of Phosphorescence
The cortical oxygen pressure was measured by oxygen-dependent quenching of phosphorescence [6, 7]. Oxyphor G2 (6 mg/mL in physiologic saline, pH 7.4; Oxygen Enterprises, Ltd, Philadelphia, PA) was intravenously injected (4.0 mg/kg body weigh). The phosphorescence lifetime measurements were made using a frequency domain PMOD 5000 phosphorometer (Oxygen Enterprises, Ltd.) with a 635 nm light-emitting diode as an excitation source and an avalanche photodiode (APD) detector. The phosphorescence signal was passed through a 695 nm long-pass filter (3 mm Schott glass, Schott North America, Elmsford, NY). The excitation light was conducted to the tissue and the phosphorescence collected by 3-mm-diameter light guides. The tips of the light guides were placed very near the surface of the dura with an 8-mm center-to-center separation. The measurements are of the mean oxygen pressure in the microvasculature.

Western Blot Analysis
Samples of frozen striatal tissue were homogenized in a buffer containing 2% sodium dodecyl sulfate (SDS), 10 mM Tris-HCl (pH 7.4) freshly supplemented with sodium fluoride (10 mM), sodium pyrophosphate (10 mM), sodium orthovanadate (1 mM), sodium molybdate (1 mM), phenylarsine oxide (1 µM), and aprotinin (10 µg/mL). The homogenate was boiled for 5 minutes after addition of SDS-polyacrylamide gel electrophoresis (PAGE) sample buffer.

Protein concentration was determined in a homogenate aliquot with a BCA Protein Assay kit (Pierce, IL). An equal amount of protein for each sample was separated by 12% SDS-PAGE and transferred onto a nitrocellulose membrane (Hybond C, Amersham Pharmacia Biotech, Piscataway, NJ). The membranes were then incubated in a blocking solution of phosphate buffered saline (PBS), pH 7.4, containing 5% nonfat milk powder for 1 hour at room temperature. The membranes were then incubated overnight with specific antibodies: ERK1 (cross-reacting with ERK2), Bax (N-20), Bcl-2 (Santa Cruz Biotechnology, Santa Cruz, CA); phospho-ERK1/2, phospho Akt, Akt (Cell Signaling Technology, Beverly, MA), and ß-actin (ABCAM, Cambridge, MA), which served as a loading control. After being washed in PBS containing 0.05% Tween 20 (PBS-T; Sigma-Aldrich, St. Louis, MO), the membranes were incubated for 1 hour with peroxidase-conjugated goat antirabbit or antimouse immunoglobulin G (Amersham Pharmacia Biotech). The final reaction was visualized using enhanced chemiluminescence (ECL Western Blotting Detection Reagents, Amersham Pharmacia Biotech.), and the membranes were exposed to x-ray film.

Data Analysis
Autoradiographic films were analyzed using Scion Image software (NIH, Bethesda, MD). Each blot contained two sets of samples, one for an experimental group and another for the control group. The data were normalized to the values obtained for the untreated control group (assigned a value of 100). Statistical analysis was performed using one-way analysis of variance, followed by the Mann-Whitney test. Statistical significance was set at p < 0.05.

All physiologic parameters and cortical oxygen pressure values are expressed as means for "n" experiments ± SD. Statistical significance was determined using one-way analysis of variance with repeated measures by Wilcoxon signed-rank test, and p < 0.05 was considered statistically significant.


    Results
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Effects on Physiologic Variables and Cortical Oxygen Pressure
Deep hypothermia cardiac arrest
Control (prebypass) values of arterial pH, PaCO 2, PaO 2, and mean arterial blood pressure (MABP) were 7.42 ± 0.03, 38.3 ± 4.6 mm Hg, 120.1 ± 16.3 mm Hg, and 76 ± 12 mm Hg, respectively. During DHCA and the 2-hour recovery, the pH and PaCO 2 were not significantly different from control. The PaO 2 and MABP decreased during DHCA to zero. During rewarming and recovery periods, the values were not significantly different than prebypass values.

Low-Flow hypothermic cardiopulmonary bypass
During LFCPB, the pH increased to 7.59 ± 0.08 (p < 0.05), PaCO 2 decreased to 18.3 ± 4.8 mm Hg (p < 0.05), and PaO 2 increased to 197.0 ± 23.6 mm Hg (p < 0.05). All blood gas values returned to prebypass levels during the recovery period. The MABP decreased to 20 ± 5 mm Hg (p < 0.005) and then, during rewarming and postbypass recovery, steadily increased. By the end of the experiments, the MABP was 63.4 ± 8 mm Hg (p < 0.05), significantly below control value.

Selective cerebral perfusion
During SCP, the pH increased to 7.79 ± 0.04 (p < 0.05), but rewarming and postbypass recovery values were not significantly different from control. PaCO 2 decreased significantly during SCP to 14.1 ± 2.2 mm Hg (p < 0.001), but PaO 2 significantly increased during SCP to 169.3 ± 18.6 mm Hg (p < 0.05). Both parameters returned to control values during recovery. The MABP decreased to 16.5 ± 4.2 mm Hg (p < 0.001) at the end of SCP and returned to control values during rewarming.

The prebypass cortical oxygen pressure was 55 ± 9 mm Hg. The cortical oxygen pressures during DHCA, LFCPB, and SCP are shown in Figure 1. The values are reported as the peak of the histograms, since this most accurately represents the microcirculation within the cortical tissue. In each case, the values were corrected to the appropriate tissue temperature (18°C for DHCA, LFCPB, and SCP). The oxygen pressure decreased during the first 5 minutes of DHCA to 2.9 ± 1.7 mm Hg (p < 0.001 versus baseline control) and was 1.1 ± 0.6 mm Hg (p < 0.001) at the end of arrest.


Figure 1
View larger version (16K):
[in this window]
[in a new window]

 
Fig 1. Effect of deep hypothermic circulatory arrest (DHCA), low-flow cardiopulmonary bypass (LF), and selective cerebral perfusion (SCP) on cortical oxygen pressure in newborn piglets. The results are means ± SD from six experiments for each group, except DHCA group (n = 8). ap < 0.001 for significant difference from control values as determined by one-way analysis of variance, followed by the Wilcoxon signed-rank test.

 
During the first 5 minutes of LFCPB and SCP, cortical oxygen pressure decreased to 9.8 ± 2.3 and 9.3 ± 1.9 mm Hg, respectively (p < 0.001), and stayed near those values until the end of bypass, when the flow was increased and rewarming was begun.

Effects on Cell Regulators in Striatum
Levels of Bcl-2
As shown in Figure 2, Bcl-2 immunoreactivity was decreased after DHCA (31% ± 9% compared with control, p < 0.01) and did not show significant changes after LFCPB and SCP (79% ± 21% and 94% ± 25%, respectively).


Figure 2
View larger version (32K):
[in this window]
[in a new window]

 
Fig 2. Effect of deep hypothermic circulatory arrest (DHCA), low-flow cardiopulmonary bypass (LFCPB), and selective cerebral perfusion (SCP) on B-cell leukemia protein (Bcl-2) and (N-terminal of Bcl-2-associated X protein (N-Bax) in the striatum of newborn piglets. (A) Representative Western blots for protein samples from DHCA, LFCPB, SCP, and control groups probed with N-Bax or Bcl-2 antibodies. (B) The means ± SD for DHCA (n = 8), LFCPB (n = 6), and SCP (n = 6) experiments, expressed in percentages to the corresponding values obtained for the control group of piglets (n = 6). ap < 0.02; bp < 0.01 for significant difference from control values as determined by one-way analysis of variance, followed by Mann-Whitney test. Statistical significance was set at p < 0.05.

 
Levels of N-Bax
After DHCA, N-Bax immunoreactivity increased (295 ± 15% compared with control, p < 0.01). Neither LFCPB nor SCP induced an increase in N-Bax immunoreactivity (128% ± 30% and 96% ± 17% compared with control, respectively) (Fig 2).

Levels of Akt
After DHCA, the phospho-Akt (pAkt) immunoreactivity did not change (121% ± 67% compared with control), as can be seen in Figure 3. LFCPB induced a significant increase in pAkt immunoreactivity (367% ± 122% compared with control (p < 0.05). SCP also caused an increase in pAkt immunoreactivity (337% ± 47%, p < 0.01; Fig 3). Measurements of total Akt immunoreactivity did not show any differences between the control and the experimental groups (Fig 3).


Figure 3
View larger version (37K):
[in this window]
[in a new window]

 
Fig 3. Effect of deep hypothermic circulatory arrest (DHCA), low-flow cardiopulmonary bypass (LFCPB), and selective cerebral perfusion (SCP) on total protein kinase B (Akt) and phosphorylated (pAkt) in the striatum of newborn piglets. (A) Representative Western blots for protein samples from DHCA, LFCPB, SCP, and control groups probed with antibodies against pAkt and total Akt. (B) The means ± SD for DHCA (n = 8), LFCPB (n = 6), SCP (n = 6) experiments are expressed in percentages to the corresponding values obtained for the control group of piglets (n = 6). ap < 0.05; bp < 0.01 for significant difference from control values as determined by one-way analysis of variance, followed by Mann-Whitney test. Statistical significance was set at p < 0.05.

 
Levels of phosphorylated ERK1/2 after 2-hour recovery
After DHCA, phospho-ERK (pERK) immunoreactivity was not significantly different compared with the value for the control group (Fig. 4). LFCPB induced significant increases in both pERK1 and pERK2 immunoreactivities (484% ± 70% and 569% ± 128%; p < 0.01, respectively) compared with control (Fig 4). Similarly, SCP caused significant increases in pERK1 and pERK2 immunoreactivities (501% ± 255%; p < 0.02 and 494% ± 162%; p < 0.01, respectively; Fig 4).


Figure 4
View larger version (48K):
[in this window]
[in a new window]

 
Fig 4. Effect of deep hypothermic circulatory arrest (DHCA), low-flow cardiopulmonary bypass (LFCPB), and selective cerebral perfusion (SCP) on total extracellular signal-regulated kinase 1/2 (ERK1/2) and phosphorylated ERK1/2 (pERK1/2) in the striatum of newborn piglets. (A) Representative Western blots for protein samples from DHCA, LFCPB, SCP, and control groups probed with antibodies against pERK1/2 and tERK1/2). (B) The means ± SD for DHCA (n = 8), LFCPB (n = 6), SCP (n = 6) experiments are expressed in percentages to the corresponding values obtained for the control group of piglets (n = 6). ap < 0.05; bp < 0.02; cp < 0.01 for significant difference from control values as determined by one-way analysis of variance, followed by Mann-Whitney test. Statistical significance was set at p < 0.05.

 
The measurements of total ERK1/2 (tERK1/2) immunoreactivity show that DHCA did not result in a significant increase in tERK1/2 compared with control (100% ± 18%; Fig 4). However, tERK1 immunoreactivity increased significantly after LFCPB and SCP (279% ± 90% and 153% ± 44%, p < 0.05, respectively; Fig 4).

To determine the extent to which the ratios of phosphorylated to dephosphorylated ERK1/2 were altered, phospho-ERK1/2 levels were normalized to the total ERK1/2. Normalized pERK1 and pERK2 levels were significantly increased in the SCP group (308% ± 30% and 467% ± 51%, respectively, p < 0.01), and normalized pERK2 levels were significantly increased in the LFCPB group (466 ± 14, p < 0.01) compared with those in control group.


    Comment
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
The present study shows that prolonged DHCA (90 minutes) was associated with increased levels of N-Bax and decreased levels of Bcl-2 but not accompanied with significant changes in pAkt and pERK1/2 levels. In contrast, the perfusion techniques of LFCPB and SCP were associated with unchanged levels of N-Bax and Bcl-2 and increased levels of pAkt and pERK1/2. The decreased Bcl-2 expression and increase in N-Bax after DHCA may be indicative of neuronal injury, whereas unaltered Bcl-2 level 2 hours after LFCPB and SCP can suggest less neuronal damage. The Bcl-2 protein family directly controls the permeability of the outer mitochondrial membrane to regulators of apoptosis and thus can control ischemic cell death. Antiapoptotic Bcl-2 is able to prevent the leakage of cytochrome C from mitochondria and to inhibit the downstream apoptotic factors.

Bax expression is altered by cerebral ischemia [8, 9], suggesting a role in ischemic neuronal death. Translocation of Bax from the cytosol to mitochondria is a central event of the apoptotic process. How exactly Bax initiates apoptosis is unknown, although the opening of channels in the mitochondrial membrane with release of peptogenic factors is probably important [10]. Using an antibody (N-20) specific to the conformationally changed (proapoptotic) state, we demonstrated that proapoptotic Bax expression was elevated after DHCA but unaltered after LFCPB or SCP. Our data clearly show early proapoptotic events after an ischemic episode. These data suggest that ischemic conditions during and after 90 minutes DHCA were severe enough to increase the risk of apoptosis within the striatum, whereas the perfusion of the brain provided by LFCPB and SCP spared activation of apoptosis.

The increase in pAkt levels associated with LFCPB and SCP may be important for neuroprotection after these procedures. Akt activation appears to protect neurons from damage after ischemia [11] and is required for neuronal survival mediated by ischemic preconditioning [12, 13]. Akt inhibits Bax conformational change and its redistribution to the mitochondrial membranes. The lack of Akt activation after DHCA could therefore contribute to the increase in proapoptotic Bax, whereas increased pAkt after LFCPB and SCP aids in maintaining the level of proapoptotic Bax within normal range.

The observed increases in ERK1/2 phosphorylation after LFCPB and SCP and the trend toward elevated phosphorylation after DHCA could have major significance on the recovery associated with these procedures. ERK1/2 is an important intermediate in cellular regulation and is thought to have roles in neuronal death and survival, although these roles seem to be complicated and altered by the type of cells and the magnitude and timing of insults [14, 15]. The activation of ERK has been reported to protect neurons against transient forebrain ischemia [16]. Furthermore, pERK1/2 is also involved in antiapoptotic activity [17] and in the development of ischemic tolerance [18].

On the other hand, several lines of evidence suggest that sustained ERK activation may indicate serious neuronal injury, possibly leading to cell death [19]. Inhibition of the ERK pathway has been shown to decrease cerebral ischemic–reperfusion injury [20]. Aharon and colleagues [4] connected the increase in expression of pERK1/2 in cerebral vascular endothelium with neuronal damage in the brain of piglets after 24 hours of recovery from normothermic CPB, DHCA, and LFCPB and concluded that ERK1/2 may play a prominent role in early cerebral ischemic–reperfusion injury. We suggest, however, that the increase in pERK induced by LFCPB and SCP can play a role in neuroprotection, whereas the lack of significant increase in pERK phosphorylation after DHCA is related to the development of striatal injury. This latter speculation is based on our previously published results that indicate at 2 hours of recovery, LFCPB [21] and SCP [22], but not DHCA [21], cause a significant increase in CREB phosphorylation and expression.

Previous reports suggest that prolonged ERK activation accompanied by an increase in CREB can be linked to cell survival and plasticity [23–25]. ERK1/2 is an upstream kinase of transcription factor CREB. CREB activation through phosphorylation induces expression of proteins involved in protective mechanisms and is associated with cell survival. Although CREB phosphorylation can be induced by other kinases, activation of ERK1/2 is necessary for inducing expression of CREB target genes, which include the anti-apoptotic protein Bcl-2. Thus, it appears that the relationship of ERK and CREB phosphorylation may ultimately determine whether cells die or survive within a given region.

The observed increases in Akt and ERK1/2 phosphorylation after LFCPB and SCP, combined with an increase in CREB phosphorylation and stable levels of Bax and Bcl-2, could be related to the tissue oxygenation. Our previous studies and results in the present study show that the peak of the brain tissue oxygen histograms was near zero during DHCA, whereas the peaks were at about 9 mm Hg during LFCPB and SCP. Thus, after 90 minutes of DHCA in which brain tissue was severely ischemic, there were no significant increases in pAkt, pERK1/2, and CREB. The latter was also accompanied by an increase in activated Bax and decreased in Bcl-2. In contrast, in LFCPB and SCP, the pAkt, pERK1/2, and CREB increased, and Bax and Bcl-2 levels remain unchanged where the hypoxia was much milder.

A limitation of this study is that we investigated only the first steps of the intrinsic (mitochondrial) signal pathway leading to apoptosis. Future experiments with a longer recovery (up to few days) will allow us to characterize the activity of caspases and the cascade of proteolytic activity after the experimental conditions we created and also validate our results with histopathologic data.

In conclusion, we suggest that the combined increases in Akt, ERK1/2, and CREB phosphorylation in the striatum after LFCPB and SCP is a likely indicator of improved chances for cell survival compared with the increase in proapoptotic form of Bax and decrease in Bcl-2 after DHCA. As such, these variables are indicative of and provide further insight into the mechanisms underlying the response of the striatum to ischemic stress caused by heart surgery. We also speculate after prolonged DHCA (90 minutes), that severe hypoxia alters gene expression and protein phosphorylation promoting apoptosis in the brain and cell death.


    Acknowledgments
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
This work was supported by National Institutes of Health (NIH) Grants, HL-58669, NS 31465 and HD-041484.


    References
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 

  1. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival Science 1998;281:1322-1325.[Abstract/Free Full Text]
  2. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts Genes Dev 1999;13:2905-2927.[Free Full Text]
  3. Wu DC, Ye W, Che XM, Yang GY. Activation of mitogen-activated protein kinases after permanent cerebral artery occlusion in mouse brain J Cereb Blood Flow Metab 2000;20:1320-1330.[Medline]
  4. Aharon AS, Mulloy MR, Drinkwater Jr DC, et al. Cerebral activation of mitogen-activated protein kinases after circulatory arrest and low flow cardiopulmonary bypass Eur J Cardiothorac Surg 2004;26:912-919.[Abstract/Free Full Text]
  5. Hetman M, Gozdz A. Role of extracellular signal regulated kinases 1 and 2 in neuronal survival Eur J Biochem 2004;271:2050-2055.[Medline]
  6. Vinogradov SA, Fernandez-Seara MA, Dugan BW, Wilson DF. Frequency domain instrument for measuring phosphorescence lifetime distributions in heterogeneous samples Rev Sci Instrum 2001;72:3396-3406.
  7. Vinogradov SA, Fernandez-Seara MA, Biruski D, Wilson DF. A method for measuring oxygen distributions in tissue using frequency domain phosphorometry Comp Biochem Physiol 2002;132:147-152.
  8. Chen J, Zhu RL, Nakayama M, et al. Expression of the apoptosis-effector gene, Bax, is up-regulated in vulnerable hippocampal CA1 neurons following global ischemia J Neurochem 1996;67:64-71.[Medline]
  9. Gillardon F, Lenz C, Waschke KF, et al. Altered expression of Bcl-2, Bcl-X, Bax, and c-Fos colocalizes with DNA fragmentation and ischemic cell damage following middle cerebral artery occlusion in rats Mol Brain Res 1996;40:254-260.[Medline]
  10. Desagher S, Martinou JC. Mitochondria as the central control point of apoptosis Trends Cell Biol 2000;10:369-377.[Medline]
  11. Yoshimoto T, Kanakaraj P, Ying Ma J, et al. NXY-059 maintains Akt activation and inhibits release of cytochrome C after focal cerebral ischemia Brain Res 2002;947:191-198.[Medline]
  12. Yano S, Morioka M, Fukunaga K, et al. Activation of Akt/protein kinase B contributes to induction of ischemic tolerance in the CA1 subfield of gerbil hippocampus J Cereb Blood Flow Metab 2001;21:351-360.[Medline]
  13. Nakajima T, Iwabuchi S, Miyazaki H, et al. Preconditioning prevents ischemia-induced neuronal death through persistent Akt activation in the penumbra region of the rat brain J Vet Med Sci 2004;66:521-527.[Medline]
  14. Nozaki K, Nishimura M, Hashimoto N. Mitogen-activated protein kinases and cerebral ischemia Mol Neurobiol 2001;23:1-19.[Medline]
  15. Chu CT, Levinthal DJ, Kulich SM, Chalovich EM, DeFranco DB. Oxidative neuronal injuryThe dark side of ERK1/2. Eur J Biochem 2004;271:2060-2066.[Medline]
  16. Park EM, Joh TH, Volpe BT, Chu CK, Song G, Cho S. A neuroprotective role of extracellular signal-regulated kinase in N-acetyl-O-methyldopamine-treated hippocampal neurons after exposure to in vitro and in vivo ischemia Neurosci 2004;123:147-154.[Medline]
  17. Zhu Y, Culmsee C, Klumpp S, Krieglstein J. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways Neurosci 2004;123:897-906.[Medline]
  18. Jones NM, Bergeron M. Hypoxia-induced ischemic tolerance in neonatal rat brain involves enhanced ERK1/2 signaling J Neurochem 2004;89:157-167.[Medline]
  19. Stanciu M, Wang Y, Kentor R, et al. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures J Biol Chem 2000;275:12200-12206.[Abstract/Free Full Text]
  20. Namura S, Iihara K, Takami S, et al. Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia Proc Natl Acad Sci USA 2001;98:11569-11574.[Abstract/Free Full Text]
  21. Zaitseva T, Schears G, Schultz S, et al. Circulatory arrest and low flow cardiopulmonary bypass alter CREB phosphorylation in piglets brain Ann Thor Surg 2005;80:245-250.[Abstract/Free Full Text]
  22. Schears G, Zaitseva T, Schultz S, et al. Brain oxygenation and metabolism during selective cerebral perfusion in neonates Eur J Cardiothorac Surg 2006;29:168-174.[Abstract/Free Full Text]
  23. Shen H, Tong L, Balazs R, Cotman CW. Physical activity elicits sustained activation of the cyclic AMP response element-binding protein and mitogen-activated protein kinase in the rat hippocampus Neuroscience 2001;107:219-229.[Medline]
  24. Sweatt JD. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory J Neurochem 2001;76:1-10.[Medline]
  25. Papadeas ST, Blake BL, Knapp DJ, Breese GR. Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement J Neuroscience 2004;24:5863-5876.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Eur J Cardiothorac SurgHome page
J. Salazar, R. Coleman, S. Griffith, J. McNeil, H. Young, J. Calhoon, F. Serrano, and R. DiGeronimo
Brain preservation with selective cerebral perfusion for operations requiring circulatory arrest: protection at 25 {degrees}C is similar to 18 {degrees}C with shorter operating times
Eur J Cardiothorac Surg, September 1, 2009; 36(3): 524 - 531.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. D. Markowitz, A. Mendoza-Paredes, H. Liu, P. Pastuszko, S. P. Schultz, G. J. Schears, W. J. Greeley, D. F. Wilson, and A. Pastuszko
Response of Brain Oxygenation and Metabolism to Deep Hypothermic Circulatory Arrest in Newborn Piglets: Comparison of pH-Stat and Alpha-Stat Strategies
Ann. Thorac. Surg., July 1, 2007; 84(1): 170 - 176.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Peter Pastuszko
David F. Wilson
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zaitseva, T.
Right arrow Articles by Pastuszko, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zaitseva, T.
Right arrow Articles by Pastuszko, A.
Related Collections
Right arrow Cerebral protection


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS